| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 12,900 | 12,900 |
| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| DENALI THERAPEUTICS | 159,840 | 159,840 |
| AQUESTIVE THERAPEUTICS INC. | 66 | 66 |
| CRESCENT ENERGY COMPANY | 133,990 | 133,990 |
| PIPESTONE ENERGY CORP | 166,596 | 166,596 |
| SANA BIOTECHNOLOGY INC | 250,000 | 250,000 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| POWER LINE PARTNERS, LP | 0 | 0 | |
| CL ROYALTY, LP | 120,038 | 120,038 | |
| SASO OFFSHORE FUND II, LP | 34,169 | 34,169 | |
| SHALE LINE PARTNERS, LP | 712,869 | 712,869 | |
| AVIATOR CAPITAL OFFSHORE, LP | 69,156 | 69,156 | |
| FW COCHISE HOLDINGS, LP | 184,498 | 184,498 | |
| CL EOF, LP - CHOWDER | 84,422 | 84,422 | |
| STAMPEDE LINE PARTNERS, LP | 1,918 | 1,918 | |
| CL SPECIALTY LENDING(CAYMAN C) | 93,731 | 93,731 | |
| CL VITA, LIMITED | 408,671 | 408,671 | |
| CL EOF, LP - LOCAL | 1,000,978 | 1,000,978 | |
| NEURO LINE PARTNERS, LP | 0 | 0 | |
| H.I. PARTNERS, LP | 47,450 | 47,450 | |
| CL DENALI CLO XIV | 263,102 | 263,102 | |
| CL EOF, LP - INDIGO | 228,173 | 228,173 | |
| CRESTLINE SUMMIT | 1,000,000 | 1,000,000 | |
| LIFE LINE PARTNERS II | 269,732 | 269,732 | |
| MONOLINE RX III, LP | 0 | 0 | |
| CURA LINE PARTNERS, LP | 435,733 | 435,733 | |
| GREEN LINE PARTNERS, LP | 348,248 | 348,248 | |
| CL CIG, LLC | 25,920 | 25,920 | |
| CL EOF, LP - FUSION | 0 | 0 | |
| FIR TREE | 0 | 0 | |
| CL EOF, LP - RESILIENCE | 375,305 | 375,305 | |
| CL WIND, LP | 164,402 | 164,402 | |
| CRESTLINE PRAETER LP-FULCRUM | 268,995 | 268,995 | |
| CONTANGO OIL AND GAS CO | 0 | 0 | |
| DENALI THERAPEUTICS | 0 | 0 | |
| CL OPPORTUNITY FUNDIV ONSHORTE | 249,657 | 249,657 | |
| CL SPECIALTY LENDING III TE/FN | 56,136 | 56,136 | |
| CRESTLINE PRAETER - HARPER | 301,348 | 301,348 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| LEGAL FEES | 2,202 | 2,202 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| OTHER INCOME FROM K-1S | 11,695 | 42,690 | |
| Misc. Income: K-1 Tax Basis Adjustment | 7,776 | 7,776 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| CONTRIBUTION PAYABLE | 1,140 | 0 |
| OTHER PAYABLE | 0 | 126,140 |
| OHA NEWBURY PARTNERS OFFSHORE (DEFICIT) | 0 | 12,884 |
| SQUARE LINE PARTNERS (DEFICIT) | 0 | 4,061 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| STATE TAXES PAID | 9 | 9 |